What is the Return on Assets (ROA) of Paion this year?
The Return on Assets (ROA) of Paion is -0.02 undefined this year.
Paion ROA 2024
Paion ROA
-0.02
Ticker
PA8.DE
ISIN
DE000A0B65S3
WKN
A0B65S
In 2024, Paion's return on assets (ROA) was -0.02, a -97.44% increase from the -0.59 ROA in the previous year.
Paion Aktienanalyse
What does Paion do?
Paion AG is a German pharmaceutical company based in Aachen. The company was founded in 2000 by four partners, including current CEO Dr. Wolfgang Söhngen. Since its founding, Paion has specialized in developing and marketing medications for sedation and anesthesia. In 2005, the company received approval for its first product, Remimazolam, a short-acting benzodiazepine that induces unconsciousness and is used in anesthesia and diagnostics. The medication has been on the market in Europe since 2020. Paion's business model is based on developing innovative medications that meet a high medical need and can succeed in the market. The company relies on intensive collaboration with its partners, including major pharmaceutical companies such as Mundipharma and Cosmo Pharmaceuticals. Paion develops its products until they are ready for the market and then transfers the marketing to its partners, allowing the company to fully focus on research and development of new medications. Over the years, Paion AG has specialized in various areas. In addition to anesthesia and sedation, the company has also made progress in neurology and oncology. Currently, Paion is developing a new medication for traumatic brain injury, which has already shown promising results in clinical trials. Another project involves the development of a treatment for lung cancer, which is also being tested in the clinical phase. Overall, Paion AG operates in various sectors and relies on close collaboration with its partners. The products offered by the company are all aimed at providing a high medical benefit and playing an important role in patient care. Paion is a dynamic company with a clear focus on innovation and growth. The health and well-being of patients are always a top priority. With its broad portfolio of innovative medications and successful collaboration with its partners, the company is well positioned to continue playing an important role in the market and expand its position as a leading provider of sedatives and anesthetics. Paion ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Paion's Return on Assets (ROA)
Paion's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Paion's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Paion's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Paion’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Paion stock
What was the ROA of Paion compared to the previous year?
The ROA of Paion has increased by -97.44% compared to the previous year.
What consequences do high ROA have for investors of Paion?
A high ROA is advantageous for investors of Paion, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Paion?
A low ROA can be unfavorable for investors of Paion as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Paion affect the company?
An increase in ROA of Paion can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Paion impact the company?
A reduction in the ROA of Paion can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Paion?
Some factors that can influence the ROA of Paion include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Paion important for investors?
The ROA of Paion is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Paion take to improve ROA?
To improve ROA, Paion can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Paion pay?
Over the past 12 months, Paion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Paion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Paion?
The current dividend yield of Paion is .
When does Paion pay dividends?
Paion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Paion?
Paion paid dividends every year for the past 0 years.
What is the dividend of Paion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Paion located?
Paion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Paion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Paion from 11/22/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/22/2024.
When did Paion pay the last dividend?
The last dividend was paid out on 11/22/2024.
What was the dividend of Paion in the year 2023?
In the year 2023, Paion distributed 0 EUR as dividends.
In which currency does Paion pay out the dividend?
The dividends of Paion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Paion stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Paion
Our stock analysis for Paion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
